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ABSTRACT
Objectives To determine the face and content validity
of items for measuring safe medication practices in
Portuguese hospitals.
Methods 128 items were drafted from content analysis
of existing questionnaires and the literature, employing
preferred terms of the WHO International Classiﬁcation
for Patient Safety (Portuguese version). A two-round
e-Delphi was convened, using a purposive
multidisciplinary panel. Hospital-based experts were
asked to rate the relevance of items on a 7-point Likert
scale and to comment on their clarity and completeness.
Results The response rate was similar in both rounds
(70.3% and 73.4%, respectively). In the ﬁrst round
91/128 (71.1%) items reached the predeﬁned level of
positive consensus. In the second round 23 additional
items reached positive consensus, as well as seven items
newly derived by the panel.
Conclusions Most items have face and content
validity, indicating relevance and clarity, and can be
included in a future questionnaire for measuring safe
medication practices in Portuguese hospitals.
INTRODUCTION
A systematic review including a total of 74 485
patients showed that nearly one out of 10 patients
had an adverse event (AE) during hospital stay;
adverse drug events (ADEs) were the second most
common type of event, after surgical AEs.1 Almost
half of the AEs were deemed preventable.1 A
Portuguese pilot study is in accordance with these
ﬁndings.2
Prevention of ADEs is imperative in view of their
clinical and economic impact and also other
unwanted effects, such as patient dissatisfaction and
loss of trust in health professionals.3
Safe medication practices aim to reduce the risk
of ADEs. If embedded in the systems approach, by
targeting “the person, the team, the task, the work-
place and the institution as a whole”,4 they may
decisively contribute to reduction of the ADE
burden. Measurement of safe medication practices
is an important step towards improvement.
Existing measurement instruments should be
adapted to each country owing to differences in
cultural and clinical practice.5 To our knowledge
there is no instrument for this purpose adapted to
the Portuguese situation. It has been suggested that
the design of measurement instruments should
include three stages: domain selection, item devel-
opment and instrument construction.5 Items should
exhibit face and content validity.5
The aim of this study is to determine the face
and content validity of items to measure safe medi-
cation practices in Portuguese hospitals.
METHODS
Instrument domains were identiﬁed based on a con-
ceptual framework by Woloshynowych et al6:
environment; tasks; organisation; staff; practices
related to the patient and others.
The starting point for item development was
content analysis of available instruments and a lit-
erature review. A total of 128 items were drafted
employing the preferred terms of the WHO
International Classiﬁcation for Patient Safety
(Portuguese version).7
Both face and content validity may be tested by
review by an expert panel;5 in this study we chose
the e-Delphi technique.8 An expert was deﬁned as
a health professional (physician, nurse, pharmacist
and pharmacy technician) working in hospital and
regularly dealing with medicines. Additional cri-
teria were professional credentials and/or status
within the profession. In view of the inclusion of
four different professional groups, the need to
ensure variability in geographical location within
the panel, hospital afﬁliation (teaching/non-
teaching) and clinical specialties, and the likely
occurrence of attrition, we set a target of 120
experts. Recruitment of experts was carried out by
the Portuguese directorate-general of health.
The ﬁrst round of open-ended questions was
replaced by previously derived items. We decided
to restrict the number of rounds to two, owing to
the length of the Delphi questionnaire. In addition
to 128 items, the ﬁrst round included two reliabil-
ity items inserted towards the end of the question-
naire, to ascertain participants’ fatigue: one was a
repeated item and one an item designed not to rep-
resent safe medication practice. Experts were asked
to rate the relevance of each item on a Likert scale,
from 1 (deﬁnitely not relevant) to 7 (deﬁnitely rele-
vant); there was also space for comments on the
completeness of each item, its wording or the
reasons underlying the rating. The ﬁnal sections of
the Delphi questionnaire consisted of space for new
items and demographic data.
Consensus was deﬁned at the outset as 75% or
more experts scoring 6 or 7 (positive consensus) or
1 or 2 (negative consensus). Failure to meet these
criteria meant that consensus was not achieved.
In round two, for each item the panel was sup-
plied with numerical feedback (overall median
score, the median score for the expert’s profes-
sional group and his own rating) and qualitative
feedback (summary of comments). Additionally,
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eight new items were added based on experts’ suggestions.
Data were input onto a SPSS database and accurateness veri-
ﬁed through a random check of questionnaires. Missing values
were excluded from analysis. Intergroup comparisons were per-
formed with Pearson’s χ2 test for a signiﬁcance level of α=0.05.
After the second round, experts’ comments were collated and
their content analysed to reﬁne the wording of the items.
RESULTS
A total of 135 experts were invited to participate. The ﬁrst
round was concluded by 95 panelists (70.4%), whereas 73.7%
(70/95) completed the second round. Attrition rate was roughly
similar in the four professional groups, ranging from 23% for
pharmacists and 29% for physicians.
The panel who concluded the second round comprised 34%
(24/70) of nurses, 24% (17/70) of pharmacists, 24% (17/70) of
pharmacy technicians and 17% (12/70) of physicians; more
panelists were female (46/70; 65.7%). The mean age of experts
was 45 years (range 27–62) and mean professional experience
was 21 years.
In round two 71% (91/128) of the items had a median score of
7 (deﬁnitely relevant) and 27% (35/128) achieved a median of 6.
Likewise, the new items were considered relevant; the majority
(6/8) obtained a median score of 7 and two had a median of 6.
As depicted in ﬁgure 1, 114 items (89%) obtained positive
consensus and no item achieved negative consensus. In addition,
seven of the eight items introduced in round two achieved con-
sensus. The repeated reliability item obtained similar median
scores as that presented at the start of the questionnaire while
the item designed not to represent safe medication practices did
not reach consensus.
Panelists’ comments shed light on possible reasons for dissent.
For example, on the item concerning the 24-hour availability of
pharmaceutical services some experts considered that an
‘on-call’ pharmacist 24/7 would sufﬁce. For standardisation of
drug administration times, a view was expressed that such a
procedure was not patient-centered, serving mainly the staff ’s
convenience. On the use of bar coding for patient identiﬁcation,
comments illustrated the belief that effective patient identiﬁca-
tion can be achieved through other procedures.
In round two agreement and consensus differed between the
four professional groups (p=0.000): physicians approved by
consensus only 88 items, whilst pharmacists approved 114
items. Table 1 provides examples of consensus obtained in the
different professional groups.
Subgroup analysis highlighted items considered deﬁnitely rele-
vant by all panelists of each professional group. Pharmacists,
nurses and pharmacy technicians unanimously assigned a score
of 7 to three items. No item was awarded a unanimous score of
7 in the physicians’ group.
DISCUSSION
This study was devised to determine the face and content valid-
ity of items for measuring safe medication practices in
Portuguese hospitals. Positive consensus was obtained on 114
items, which indicates relevance and clarity. Reﬁnement of the
wording of items in light of experts’ comments further
enhanced their content validity. Endorsement of many safe
medication practices accepted internationally by Portuguese
experts is a new ﬁnding. Another strength of this study is the
relatively large nationwide panel convened. For example, in a
systematic review on the use of the Delphi method for selecting
healthcare quality indicators, the median number of participants
was 17.9 Although there are no deﬁnitive guidelines on panel
size, larger panels may improve reliability.
One limitation of this study is the lack of sound evidence
underpinning some items. Consensus reﬂects experts’ opinion
and should not be regarded as unconditional truth. For
example, ‘tall-man’ letters were endorsed by panelists as a way
of preventing mix-ups with look-alike, sound-alike medication.
Although encouraged by WHO10 and the Institute for Safe
Medication Practices,11 the evidence supporting this practice
Figure 1 Overview of the Delphi results.
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consists primarily of laboratory-based studies, using name recog-
nition as an outcome measure (and not medication incidents or
ADE prevention). A recent before-and-after study in 42 paediat-
ric American hospitals on the frequency of these errors after
‘tall-man’ lettering was introduced found no statistically signiﬁ-
cant change in either their intercept or rate for 11 look-alike,
sound-alike pairs.12 These ﬁndings call for further research in
adult populations to determine for which drug pairs, if any,
‘tall-man’ letters are effective, and highlight the need for multi-
modal error prevention practices.
This study was not set up to construct an instrument to
measure safe medication practices; given the number of poten-
tially important items, a stepwise approach was adopted, focus-
ing ﬁrst on item selection. This is in line with existing
approaches and should not be seen as a limitation.3
Subgroup analysis showed the existence of a statistically signiﬁ-
cant difference in the number of consensus-approved items
between professions. This inﬂuence of panel composition has been
described9 and supports our decision to use a heterogeneous panel.
Despite attrition, which is common in Delphi panels, we
achieved a response rate >70% in both rounds. According to
Walker and Selfe, this is the minimum threshold required to
maintain rigour in data collection.13 The questionnaire length
might have been an important factor in explaining attrition.
CONCLUSIONS
Most items subjected to scrutiny reached the predeﬁned level of
positive consensus, indicating relevance and clarity for measur-
ing safe medication practices in Portuguese hospitals.
Future steps are needed to develop an instrument for this
purpose with sound psychometric characteristics. However, the
safe medication practices endorsed by this panel may be useful
to identify and prioritise areas in need of improvement by
hospitals.
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